10:17 AM EDT, 06/02/2025 (MT Newswires) -- (Updates with comment from Hims & Hers Health ( HIMS ) in the fourth paragraph.)

Hims & Hers Health ( HIMS ) is laying off 68 staffers, or nearly 4% of its staff, across various teams, multiple media outlets reported Friday, citing a company representative.

The layoffs were not related to the US Food and Drug Administration ban on compounded copies of Novo Nordisk's (NVO) weight loss drug Wegovy, Reuters quoted a Hims & Hers spokesperson as saying.

Hims & Hers did not specify the roles affected by the move but said it expects the layoffs to support its business plan execution, Bloomberg News reported.

A Hims & Hers spokesperson told MT Newswires the changes are focused on sharpening how the company executes, without affecting its priorities or the specialties it's committed to. The company added it will continue actively hiring for roles critical to its long-term strategy.

Price: 56.12, Change: -0.41, Percent Change: -0.73